Geron
GERN
#6280
Rank
NZ$1.44 B
Marketcap
NZ$2.27
Share price
3.15%
Change (1 day)
-66.49%
Change (1 year)

Revenue for Geron (GERN)

Revenue in 2025 (TTM): NZ$0.31 Billion

According to Geron's latest financial reports the company's current revenue (TTM ) is NZ$0.31 Billion. In 2024 the company made a revenue of NZ$0.13 Billion an increase over the revenue in the year 2023 that were of NZ$0.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Geron from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$0.31 B131.54%
2024 NZ$0.13 B36328.67%
2023 NZ$0.37 M-60.08%
2022 NZ$0.93 M-53.97%
2021 NZ$2.03 M481.63%
2020 NZ$0.35 M-48.66%
2019 NZ$0.68 M-57.02%
2018 NZ$1.58 M5.98%
2017 NZ$1.49 M-83.14%
2016 NZ$8.89 M-83.26%
2015 NZ$53.14 M3511.21%
2014 NZ$1.47 M-5.75%
2013 NZ$1.56 M-52.59%
2012 NZ$3.29 M5.42%
2011 NZ$3.12 M-32.36%
2010 NZ$4.61 M94.35%
2009 NZ$2.37 M-50.8%
2008 NZ$4.83 M-51.46%
2007 NZ$9.95 M113.92%
2006 NZ$4.65 M996.32%
2005 NZ$0.42 M
2003 NZ$1.45 M-32.87%
2002 NZ$2.17 M-75.08%
2001 NZ$8.71 M-41.55%
2000 NZ$14.91 M43.11%
1999 NZ$10.42 M-19.24%
1998 NZ$12.9 M2.57%
1997 NZ$12.57 M67.69%
1996 NZ$7.5 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
NZ$0 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$50.34 B 15,759.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$2.10 B 563.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$8.33 B 2,524.33%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$0.13 B-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA